Aquestive Therapeutics Inc (AQST)vsViatris Inc (VTRS)
AQST
Aquestive Therapeutics Inc
$3.46
-6.61%
HEALTHCARE · Cap: $491.44M
VTRS
Viatris Inc
$19.63
-1.26%
HEALTHCARE · Cap: $23.90B
Smart Verdict
WallStSmart Research — data-driven comparison
Viatris Inc generates 30055% more annual revenue ($14.73B vs $48.84M). VTRS leads profitability with a -4.1% profit margin vs -162.3%. VTRS earns a higher WallStSmart Score of 40/100 (D).
AQST
Avoid18
out of 100
Grade: F
VTRS
Hold40
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-52.8%
Fair Value
$2.50
Current Price
$3.46
$0.96 premium
Margin of Safety
-80.4%
Fair Value
$8.94
Current Price
$19.63
$10.69 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Reasonable price relative to book value
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 0.0% — below average capital efficiency
Weak financial health signals
Expensive relative to growth rate
ROE of -4.4% — below average capital efficiency
Revenue declined 0.3%
Earnings declined 70.6%
Comparative Analysis Report
WallStSmart ResearchBull Case : AQST
The strongest argument for AQST centers on Debt/Equity.
Bull Case : VTRS
The strongest argument for VTRS centers on Price/Book.
Bear Case : AQST
The primary concerns for AQST are EPS Growth, Market Cap, Return on Equity.
Bear Case : VTRS
The primary concerns for VTRS are PEG Ratio, Return on Equity, Revenue Growth.
Key Dynamics to Monitor
AQST carries more volatility with a beta of 1.50 — expect wider price swings.
VTRS is growing revenue faster at -0.3% — sustainability is the question.
VTRS generates stronger free cash flow (814M), providing more financial flexibility.
Monitor DRUG MANUFACTURERS - SPECIALTY & GENERIC industry trends, competitive dynamics, and regulatory changes.
Bottom Line
VTRS scores higher overall (40/100 vs 18/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Aquestive Therapeutics Inc
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC · USA
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and marketing various products to address unmet medical needs in the United States and internationally. The company is headquartered in Warren, New Jersey.
Viatris Inc
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC · USA
Viatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania.
Visit Website →Compare with Other DRUG MANUFACTURERS - SPECIALTY & GENERIC Stocks
Want to dig deeper into these stocks?